Table 3. Cytology by HPV status.
Cytology
|
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
20–29 years
|
30–64 years
|
All ages
|
1904 women with a single HPV infection
|
||||||||||
HPV type | Negative | B/M* | Mod+* | Negative | B/M | Mod+ | Negative | B/M | Mod+ | Total | Negative | B/M | Mod+ |
16 | 184 | 202 | 113 | 136 | 75 | 95 | 320 (39.8%) | 277 (34.4%) | 208 (25.8%) | 805 (100%) | 235 (45.5%) | 146 (28.3%) | 135 (26.2%) |
18 | 93 | 74 | 24 | 67 | 41 | 20 | 160 (50.2%) | 115 (36.1%) | 44 (13.8%) | 319 (100%) | 96 (56.1%) | 53 (31.0%) | 22 (12.9%) |
31 | 83 | 67 | 35 | 62 | 46 | 33 | 145 (44.5%) | 113 (34.7%) | 68 (20.9%) | 326 (100%) | 97 (53.3%) | 53 (29.1%) | 32 (17.6%) |
33 | 45 | 58 | 27 | 21 | 22 | 10 | 66 (36.1%) | 80 (43.7%) | 37 (20.2%) | 183 (100%) | 32 (41.6%) | 31 (40.3%) | 14 (18.2%) |
35 | 23 | 20 | 6 | 28 | 25 | 6 | 51 (47.2%) | 45 (41.7%) | 12 (11.1%) | 108 (100%) | 31 (52.5%) | 23 (39.0%) | 5 (8.5%) |
39 | 67 | 71 | 21 | 56 | 38 | 13 | 123 (46.2%) | 109 (41.0%) | 34 (12.8%) | 266 (100%) | 78 (60.5%) | 46 (35.7%) | 5 (3.9%) |
45 | 47 | 33 | 14 | 58 | 28 | 10 | 105 (55.3%) | 61 (32.1%) | 24 (12.6%) | 190 (100%) | 59 (64.8%) | 24 (26.4%) | 8 (8.8%) |
51 | 70 | 99 | 20 | 63 | 40 | 13 | 133 (43.6%) | 139 (45.6%) | 33 (10.8%) | 305 (100%) | 83 (50.6%) | 69 (42.1%) | 12 (7.3%) |
52 | 96 | 88 | 27 | 82 | 57 | 17 | 178 (48.5%) | 145 (39.5%) | 44 (12.0%) | 367 (100%) | 105 (56.1%) | 68 (36.4%) | 14 (7.5%) |
56 | 43 | 46 | 9 | 40 | 38 | 6 | 83 (45.6%) | 84 (46.2%) | 15 (8.2%) | 182 (100%) | 48 (53.3%) | 38 (42.2%) | 4 (4.4%) |
58 | 40 | 45 | 12 | 32 | 24 | 15 | 72 (42.9%) | 69 (41.1%) | 27 (16.1%) | 168 (100%) | 49 (57.6%) | 24 (28.2%) | 12 (14.1%) |
59 | 69 | 44 | 12 | 46 | 20 | 8 | 115 (57.8%) | 64 (32.2%) | 20 (10.1%) | 199 (100%) | 74 (69.8%) | 27 (25.5%) | 5 (4.7%) |
68 | 27 | 19 | 4 | 27 | 13 | 4 | 54 (57.4%) | 32 (34.0%) | 8 (8.5%) | 94 (100%) | 34 (72.3%) | 11 (23.4%) | 2 (4.3%) |
16 and/or 18 | 265 | 260 | 129 | 198 | 111 | 114 | 463 (39.8%) | 371 (34.4%) | 243 (22.6%) | 1077 (100%) | — | — | — |
Any HR-HPV | 651 | 556 | 197 | 619 | 362 | 199 | 1270 (43.0%) | 918 (35.5%) | 396 (15.3%) | 2584 (100%) | — | — | — |
hc2+ No HR-HPV | 236 | 88 | 5 | 704 | 147 | 9 | 940 (49.1%) | 235 (19.8%) | 14 (1.2%) | 1189 (100%) | — | — | — |
hc2− | 3119 | 286 | 12 | 16 035 | 1211 | 34 | 19 154 (79.1%) | 1497 (7.2%) | 46 (0.22%) | 20 697 (100%) | — | — | — |
All women | 4006 | 930 | 214 | 17 358 | 1720 | 242 | 21 364 (92.5%) | 2650 (10.8%) | 456 (1.9%) | 24 470 (100%) | 1021 | 613 | 270 |
No. of HR-HPVs detected | 887 | 866 | 324 | 718 | 467 | 250 | 1605 | 1333 | 574 | 3512 | 1021 | 613 | 270 |
B/M=borderline/mild dyskaryosis; HR-HPV=high-risk human papillomavirus; Mod+=moderate dyskaryosis or worse.
Results by age (20–29, 30–64 years), overall, and in 1904 women with a single HPV type.